RxDoctor Payments Data

Trey Gunter, MD

Family Medicine · Dawsonville, GANPI 1700264728

Payments from drug & device makers

$10,141in general payments, 2019–2025

Across 608 payments — averaging $16.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$1K
  • Boehringer Ingelheim$976
  • Amgen$623
  • Lilly USA, LLC$615
  • Amarin Pharma, Inc.$574
  • plus $5K from 33 others

What the payments were for

  • Food & beverage$10,092100%
  • Education$490%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,141 in reported general payments places this provider in the 90th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$165,683
Medicare patients
363
Services billed
3,066

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$97,317
EliquisApixaban73$90,200
TrulicityDulaglutide48$78,283
JardianceEmpagliflozin64$76,722
FarxigaDapagliflozin Propanediol62$73,656
MounjaroTirzepatide52$69,452
ProliaDenosumab37$62,489
RybelsusSemaglutide35$44,335
ArexvyRsvpref3 Antigen/As01e/Pf140$42,768
Trelegy ElliptaFluticasone/Umeclidin/Vilanter59$42,022
Soliqua 100-33Insulin Glargine/Lixisenatide36$37,011
Repatha SureclickEvolocumab35$27,054
JanuviaSitagliptin Phosphate23$23,128
XareltoRivaroxaban21$17,571
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog17$14,595

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$615$147,735100 claims
Novo NordiskOzempic, Rybelsus$1,417$141,65191 claims
GSKArexvy, Trelegy Ellipta, Anoro Ellipta, Shingrix$469$103,594261 claims
PfizerEliquis$481$90,20073 claims
AstraZenecaFarxiga, Bevespi Aerosphere, Symbicort$1,169$81,88590 claims
Boehringer IngelheimJardiance$976$76,72264 claims
AmgenProlia$623$62,48937 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$483$37,01136 claims
MerckJanuvia, Janumet$186$34,65635 claims
Johnson & JohnsonXarelto$118$17,57121 claims
AbbVieSynthroid$389$3,95048 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Dawsonville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →